Metastatic Cancer Drug Market Forecast to 2028

1
Metastatic Cancer Drug Market 
Metastatic Cancer Drug Market Forecast to 2028 -
COVID-19 Impact and Global Analysis By Cancer
Type (Breast Cancer, Lung Cancer, Liver Cancer,
Hematological Cancer, Brain Cancer, Prostate
Cancer, Pancreatic Cancer, and Others), Route of
Administration (Intravenous, Intramuscular, Oral,
and Others), Drug Class (HER2 Inhibitor, Immune
Checkpoint Inhibitor, PARP Inhibitor, Kinase
Inhibitor, and Others), Product (Branded and
Generic Biosimilar), and End User (Hospital,
Specialty Clinic, and Others)
2
Current and future Market Scenario
Metastatic Cancer Drug Market 
The metastatic cancer drug market size is
projected to reach US 68,349.54 million by 2028
from US 51,157.97 million in 2021. It is
expected to grow at a CAGR of 4.2 from 2021 to
2028.
3
Market Segments
Metastatic Cancer Drug Market   
Cancer Type Breast Cancer Lung Cancer Liver
Cancer Hematological Cancer Brain Cancer Prostate
Cancer Pancreatic Cancer
Route of Administration Intravenous Intramuscular
Oral Others
Drug Class HER2 Inhibitor Immune Checkpoint
Inhibitor PARP Inhibitor Kinase Inhibitor Others
4
Leading Players
Metastatic Cancer Drug Market  
Company Profiles in Metastatic Cancer Drug Market
are AbbVie Inc. Amgen Inc. Bristol-Myers Squibb
Company F. HOFFMANN-LA ROCHE LTD. Novartis
AG ASTRAZENECA PLC. Eli Lilly and Company MERCK
KGaA Pfizer Inc. (Arena Pharmaceutical GmbH).
5
Metastatic Cancer Drug Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/metasta
tic-cancer-drug-market
Thank You!

• Thank You!